This editorial, published in Frontiers in Psychiatry, introduces a curated collection of research exploring Traditional Chinese Medicine (TCM) as a multi-target, holistic approach to treating depression and anxiety. It highlights how herbal formulas, acupuncture, and mind-body exercises can complement conventional treatments by addressing the complex, heterogeneous nature of mental health disorders.
TL;DR
This editorial summarizes a research collection that positions Traditional Chinese Medicine (TCM) as a holistic, multi-target alternative to conventional "single-target" antidepressants. By integrating network pharmacology, clinical trials, and meta-analyses, the featured papers explore how herbal formulas and acupuncture can address the high heterogeneity of depression and anxiety.
What Problem Does This Paper Address?
Depression and anxiety are the most prevalent mental disorders globally, yet current pharmacological treatments often fall short. The authors point out that conventional "single-target" antidepressants and anxiolytics suffer from low response and remission rates. This is largely due to the high heterogeneity of these conditions—symptoms and underlying causes vary wildly between patients.
Traditional Chinese Medicine (TCM) has been used for centuries to treat these ailments through "holism" and "syndrome pattern differentiation." However, the clinical effectiveness and specific biological mechanisms of TCM are not yet fully illustrated in the context of modern evidence-based medicine. This editorial introduces a Research Topic designed to provide a forum for state-of-the-art research on TCM’s role in mental health.
Methods
As an editorial, this paper synthesizes findings from five distinct studies that utilized various modern research methodologies to evaluate TCM:
- Systematic Literature Review: Identifying antidepressant activities in 45 specific herbal medicines.
- Network Pharmacology & Molecular Docking: Mapping the 91 active compounds in the Sinisan Formula (SNSF) to 112 depression-related targets.
- Network Meta-Analysis: Evaluating the efficacy and safety of various acupuncture-related therapies.
- Clinical Pilot Trials: Investigating electroacupuncture for perioperative anxiety in cancer patients.
- Integrative Clinical Studies: Combining conventional treatments with mindfulness and TCM mind-body exercises (e.g., Tai Chi, Baduanjin).
Datasets
The editorial references several types of data sources used across the five highlighted articles:
- In vitro and in vivo study data: Used to identify the 45 antidepressant herbal medicines.
- Pharmacological Databases: Used for the network mapping of the Sinisan Formula.
- Clinical Trial Data: Including a single-center pilot trial for surgical patients and meta-analyses of existing acupuncture trials.
- Neuroimaging (fMRI): Mentioned in the context of future directions for identifying biomarkers for individualized intervention.
Key Insights and Ideas
- The Multi-Target Advantage: Unlike the "one drug, one target" model of Western medicine, TCM formulas like SNSF interact with hundreds of targets simultaneously. This may allow for a broader regulation of signaling pathways (neurotransmitters, neurogenesis, anti-inflammation, etc.) while potentially reducing side effects.
- Syndrome Pattern Differentiation: TCM doesn't treat "depression" as a monolith. Instead, it uses "syndrome pattern differentiation" (inspection, listening, inquiry, palpation) to tailor treatment to the individual's specific physiological state.
- Holism in Mental Health: TCM views the human body as a whole in relation to nature and society. This aligns with the modern biopsychosocial model of psychiatry, suggesting that mental health cannot be treated in isolation from physical health or environment.
- Acupuncture as a Safe Adjunct: Research indicates that acupuncture is particularly effective and safe for specific comorbidities, such as anxiety and depression in patients with Irritable Bowel Syndrome (IBS-D).
Key Results
- Herbal Mechanisms: 45 herbs were identified with antidepressant activity, working through pathways involving neurogenesis, antioxidation, and the gut microbiota.
- SNSF Mapping: The Sinisan Formula was shown to regulate 5-hydroxytryptamine (serotonin), dopamine, and GABA pathways through its 91 active compounds.
- Mind-Body Synergy: Combining conventional treatment with 4–12 weeks of mindfulness or TCM exercises (Tai Chi) significantly improved symptoms in patients with insomnia and anxiety.
- Surgical Support: Electroacupuncture showed promise in reducing perioperative anxiety and stress responses in patients undergoing major cancer surgery.
Limitations and Future Work
The authors acknowledge several hurdles in bringing TCM into mainstream psychiatric practice:
- Methodological Mismatch: Standardized clinical trial designs are often a poor fit for TCM’s individualized, holistic approach. There is a need for new research methodologies that respect TCM's characteristics.
- Sample Sizes: Many current clinical trials (like the electroacupuncture pilot) are small and single-center, limiting their generalizability.
- Standardization: The selection of "acupoints" in acupuncture studies varies significantly, making it difficult to create universal clinical protocols.
- Future Directions: The authors suggest using advanced technology, such as personalized fMRI, to discover biomarkers that can bridge the gap between TCM's individualized diagnosis and modern objective measurements.
Summary updated